A randomised, double blind placebo-controlled study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of multiple ascending doses of intrathecally administered ISIS 443139 in patients with early manifest Huntingtons disease - Porth Ymchwil

Teitl: A randomised, double blind placebo-controlled study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of multiple ascending doses of intrathecally administered ISIS 443139 in patients with early manifest Huntingtons disease

Arianwyr
Ionis Pharmaceuticals Inc

Prif Ymchwiliwr

Rosser, Anne

Manylion y Prosiect

Gwerth net y ffigur a ddyfarnwyd i Brifysgol Caerdydd: £99,991.00

Dyddiad dechrau: 01.01.2017

Dyddiad gorffen: 31.12.2019